Archive · 24 Sep 2026
Government Revives Pharma Logistics Study to Map Future Needs
The government wants to understand how medicines and medical devices move from factories to customers.
It has restarted a study and issued a new tender.
The study will look at roads, storage, cold rooms, customs and delivery times.
It will cover products used in the country and products sent abroad.
The consultant will decide which problems deserve the most attention.
The study will also estimate what infrastructure may be needed during the next 10 years.
It may suggest using artificial intelligence and blockchain to track shipments.
One consultant or a group of up to three companies will complete the work in six months.
The Department of Pharmaceuticals has issued a revised tender for a pharma and medical-device logistics study.
The consultant will identify priority areas independently rather than follow government-prescribed focus areas.
The study will examine logistics costs, transit times, infrastructure, cold chains, customs and multimodal connectivity.
It will cover domestic and export value chains, including raw materials, APIs, diagnostics and last-mile delivery.
One consultant, including a consortium of up to three entities, will have six months to complete the study.
- Who
- The Department of Pharmaceuticals will appoint one consultant, potentially a consortium or joint venture of up to three entities.
- What
- A revised tender seeks a study of pharma and medical-device logistics infrastructure, supply chains, regulations and future capacity needs.
- When
- The consultant will have six months to complete the study; the articles do not specify the study’s start date.
- Where
- The study will cover domestic and export value chains, including logistics from raw-material sourcing to last-mile delivery.
- Why
- The government wants to identify infrastructure and policy gaps, guide investment and reduce delays and logistics costs.
- Commissioning agency
- Department of Pharmaceuticals
- Planning horizon
- The next 10 years
- Scope
- Pharmaceuticals and medical devices, including APIs and diagnostics
- Areas assessed
- Transport, storage, cold chains, customs and multimodal connectivity
- Technology focus
- Artificial intelligence and blockchain for logistics and tracking
- Consultant structure
- One consultant; a consortium or joint venture may include up to three entities
- Completion period
- Six months